ED
PTEN icon

Exane Derivatives’s Patterson-UTI PTEN Stock Holding History

Exane Derivatives’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$25.4K Sell
1,613
-2,258
-58% -$37.9K 0.01% 354
2022
Q1 		$59.9K Sell
3,871
-295
-7% -$3.72K 0.02% 552
2021
Q4 		$35.2K Buy
+4,166
New +$35.9K 0.01% 541

Other funds holding PTEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
ACM
Anomaly Capital Management New York $2.62B AUM 23.26% 1-Year Est. Return
KBG
Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Exane Derivatives's PTEN Position: Q2 2022 in Review

Exane Derivatives reduced its Patterson-UTI (PTEN) stake by 58% in Q2 2022, selling an estimated $37.9K and leaving 1,613 shares worth $25.4K. The position accounts for 0.01% of the portfolio, ranked #354.

Exane Derivatives first reported a position in PTEN in Q4 2021 and has held it in 3 quarters since. The position peaked at $59.9K in Q1 2022. 267 funds tracked by Wall St. Rank hold PTEN as of Q2 2022.

  • Exane Derivatives held 1,613 shares of Patterson-UTI worth $25.4K as of Q2 2022.
  • Exane Derivatives sold 2,258 Patterson-UTI shares in Q2 2022, an estimated $37.9K.
  • Patterson-UTI made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #354 holding.
  • Exane Derivatives first reported a position in Patterson-UTI in Q4 2021 and has held it in 3 quarters since.
  • Exane Derivatives's Patterson-UTI position peaked at $59.9K in Q1 2022.
  • 267 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.